United States · FDA National Drug Code directory

Adderall XR

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 54092-385_38ac432b-672e-4dd1-8af5-bea373aa5f3f
Product NDC: 54092-385
Form: CAPSULE, EXTENDED RELEASE
Composition / generic term: Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate
Labeler: Takeda Pharmaceuticals America, Inc.
Marketing category: NDA
Marketing start / end (source format): 20020522
Source listing expiry: 20271231

Source-listed ingredients

DEXTROAMPHETAMINE SULFATE — 3.75 mg/1
DEXTROAMPHETAMINE SACCHARATE — 3.75 mg/1
AMPHETAMINE ASPARTATE MONOHYDRATE — 3.75 mg/1
AMPHETAMINE SULFATE — 3.75 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-385-01) · 54092-385-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →